Skip to main content
. 2022 Mar 28;23(2):397–409. doi: 10.1007/s10238-022-00810-7

Table 3.

Intra hepatic IL 34, MCSF or CD68+ TAMs in different clinical features of patients with HBV-HCC (n = 30)

Characteristics N IL-34 MCSF CD68+ TAMs
Median p value Median p value Median p value
HBV-DNA (IU/mL)
  < 5*102 15 35.7  < 0.001 122.3  < 0.01 21.5  < 0.05
  ≥ 5*102 11 49.4 56.3 26.3
HBeAg
 HBeAg 10 45.3  < 0.01 134.7  < 0.05 25.8 Ns
 HBeAg+ 3 24.6 50.0 23.0
AFP
 Normal 14 44.4 Ns 57.2  < 0.05 19.2  < 0.0001
 Abnormal 16 43.0 101.2 27.2
Differentiation
  ≤ II 10 54.9  < 0.05 90.3 ns 16.5  < 0.0001
  > II 19 34.8 75.1 26.1
Tumor number
 1 22 43.4 ns 89.1  < 0.05 20.1  < 0.0001
  ≥ 2 7 39.1 46.0 31.7
Tumor size
  ≤ 5 12 53.9  < 0.0001 66.0 ns 25.0  < 0.001
  > 5 17 34.8 88.1 21.0

All datum was *103 image unites. The reference range of AFP is 0–9 μg/L. The histopathological classification is well described in the published Literature